# The impact of pH on proteolytic activity in wound fluid: Implications for acid therapy

**Authors:** Elany Barbosa da Silva, Meredith J. Crane, Lawrence Liu, Danielle J. Gelsinger, Alexander R.D. Jordon, Phuong Le, Jack G. Haggett, Samuel A. Myers, Robin L. McKinney, Craig P. Eberson, Amanda M. Jamieson, Anthony J. O’Donoghue

PMC · DOI: 10.1016/j.jbc.2025.110723 · The Journal of Biological Chemistry · 2025-09-15

## TL;DR

This study explores how different pH levels affect protease activity in wound fluid, revealing that acid therapy may promote healing by activating specific enzymes like cathepsin D.

## Contribution

The study identifies cathepsin D as a key enzyme activated at acidic pH and validates a mouse model for acid-mediated wound healing.

## Key findings

- Proteases active at pH 7.4 are inactivated at pH 3.5.
- Cathepsin D is the dominant active enzyme at pH 3.5 and is inhibited by pepstatin.
- Human wound fluid mirrors mouse wound fluid activity profiles, validating the mouse model.

## Abstract

Wound healing necessitates a balance between synthesis and breakdown of extracellular matrix components, which is tightly regulated by proteases and their inhibitors. While studies have demonstrated that citric and acetic acid treatments enhance healing in recalcitrant wounds, the underlying proteolytic mechanisms remain elusive. In this study, we systematically evaluated changes in the proteolytic activity of murine wound fluid upon acidification. A library of 228 synthetic peptides served as reporters of protease activity at pH 7.4, pH 5.0, and pH 3.5. The peptide digestion patterns differed at each pH, revealing that proteases active at pH 7.4 are inactivated at pH 3.5. Notably, cathepsin D emerged as the dominant active enzyme at pH 3.5, and its activity was inhibited by pepstatin. Using a fluorogenic substrate, we quantified cathepsin D activity across varying pH levels and demonstrated optimal activity between pH 3.0 and 3.8. This activity was detectable as early as 1 day postinjury and persisted over the following 10 days. Importantly, human wound fluid exhibited the same activity profile, validating the mouse model as a relevant system for studying acid-mediated wound healing processes.

## Linked entities

- **Chemicals:** citric acid (PubChem CID 311), acetic acid (PubChem CID 176), pepstatin (PubChem CID 5478883)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ctsd (cathepsin D) [NCBI Gene 13033] {aka CD, CatD}
- **Chemicals:** peptides (MESH:D010455), pepstatin (MESH:C031375), acetic acid (MESH:D019342), citric (MESH:D019343)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12550788/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12550788/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12550788/full.md

---
Source: https://tomesphere.com/paper/PMC12550788